Ali ÇAYKÖYLÜ, Murat İlhan ATAGÜN, Serdar Süleyman CAN, Çağlar SOYKAN, Derya BÜYÜKÖZ, Şükrü Alperen KORKMAZ

Serum lithium levels are associated with white blood cell counts in bipolar disorder

PDF

___

1. Canan F, Dikici S, Kutlucan A, Celbek G, Coskun H, Gungor A, Aydin Y, Kocaman G. Association of mean platelet volume with DSM-IV major depression in a large community-based population: the MELEN study. J Psychiatr Res 2012; 46: 298- 302.
2. Miller BJ, Kandhal P, Rapaport MH, Mellor A, Buckley P. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses. Brain Behav Immun 2015; 45: 28-35.
3. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, Marzec U, Harker LA, Nemeroff CB. Exaggerated platelet reactivity in major depression. Am J Psychiat 1996; 153: 1313-1317.
4. Focosi D, Azzarà A, Kast RE, Carulli G, Petrini M. Lithium and hematology: established and proposed uses. J Leukocyte Biol 2009; 85: 20-28.
5. Nasreddine W, Beydoun A. Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia 2008; 49: 438-445.
6. Ataoglu A, Canan F. Mean platelet volume in patients with major depression: effect of escitalopram treatment. J Clin Psychopharm 2009; 29: 368-371.
7. Semiz M, Yucel H, Kavakci O, Yildirim O, Zorlu A, Yilmaz MB, Küçükdurmaz Z, Canan F. Atypical antipsychotic use is an independent predictor for the increased mean platelet volume in patients with schizophrenia: a preliminary study. J Res Med Sci 2013; 18: 561-566.
8. Jope RS. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 2003; 24: 441-443.
9. Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells. Curr Biol 1996; 6: 1664-1668.
10. Ozdemir MA, Sofuoğlu S, Tanrikulu G, Aldanmaz F, Eşel E, Dündar S. Lithium-induced hematologic changes in patients with bipolar affective disorder. Biol Psychiat 1994; 35: 210-213.